Zevra’s Arimoclomol Brings Efficacy Questions To First Genetic Metabolic Diseases Adcomm

 
• By Sue Sutter
Wrapped package
The FDA's external advisors will consider a package of confirmatory trial evidence for arimoclomol. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers